Research at Fox Chase »Technology Transfer »Technology Licensing

The technologies listed below are available for licensing. Technologies are listed by type: Therapeutic Targets; Research Methods, Screens and Assays; Reagents; and Software.

Contact us by email, fax or by phone for licensing information.

Proton Beam Radiotherapy

1. Particle Selection, Beam Monitoring and System Design for Laser-Accelerated Ion/Ion Beams for Radiotherapy (#03-12) - This invention provides significant advances in proton beam radiotherapy.
   Building an Enormous Cancer Killer [PDF]
   (Philadelphia Inquirer, 10-10-2006)

Therapeutics and Discovery Targets

Cancer

• Markers for Renal Cancer Diagnosis and Prognosis [DOC]
• Novel Methods for Inhibiting Angiogenesis [DOC]
• Markers for Early Diagnosis of Cancer [DOC]
• MED1 - A Novel Gene Associated with Cancer Drug Resistance [PDF]
• Human BUB Genes: Mitotic Checkpoint Kinases [PDF]
• p53 repression elements in the Surviving and MAP4 promoters [PDF]
• OVCA1 and OVCA2 Tumor Suppressor Genes
• Tumor-specific Antisense Therapy to Inhibit Bcl-2 Expression and Induce Apoptosis for Treatment of non-Hodgkin's Lymphoma
• Hef1/Cas-L, a Novel Signal Transduction Molecule Associated with Cell Motility, Growth, Apoptosis and Oncogenic Transformation [PDF]
• Pregnancy-Associated Genetic Signatures in the Human Breast
  More | PDF

Antibiotics, Industrial Chemicals & Herbicides

• Porphobilinogen Synthase - A Novel Target for Antibiotic, Industrial Chemical and Herbicide Development

HIV/AIDS

• ATR Kinase [PDF] - A Novel Target for Anti-Retroviral Drug Discovery

Cancer, HIV, Urology

• MRP-Related Transporter Genes Involved in Resistance to Cytotoxic Chemotherapeutic Drugs

Research Methods, Screens, and Assays

• ELISA Assay for the Detection of Ectromelia and Vaccinia Virus Antibodies in Mice, using Recombinant Viral Proteins [PDF]
• The Two-Hybrid Dual Bait System: An Improved Two-Hybrid System for the Detection of Protein-Protein Interactions
• A Yeast Bioassay System for the Identification of Compounds that can Lower Plasma Homocysteine Levels
• p53-Dependent Asymmetric Cell Division: A Novel Screen for Growth Regulatory Compounds
• A Novel Tumor Cell Marker for use in Evaluating Cancer Therapeutics
• A Novel Cell Cycle-Specific Kinetochore Protein that Distinguishes G2 and M-Phase Cells

Animal Models

• Fox Chase MISIIR-TAg Mouse [DOC]
  - A New Model of Epithelial Ovarian Cancer

Vectors, Antibodies, Reagents & Cell Lines

• Vectors
  • PGLS20 vector: A novel dual purpose vector for protein expression in E.coli and S.cerevisiae [PDF]
  • A Mutated Human Cytomegalovirus Expression Vector with Enhanced Ability to Express Foreign Genes
  • A Chimeric Integrase-Containing Expression Vector for Promoting Targeted Integration of Foreign DNA into a Host Genome
  • Expression vectors for MRP4 and MRP6 multidrug resistance genes
• Polyclonal Antibodies: HEPL, ATM, FAP and PIX
• Monoclonal Antibodies: MAD1/2, HIRA, ASF1a, HEF, all Bub reagents, and CENP-E
• Endonucleases
  • MED1 Glycosylase, a Tool for Detection of transition SNPs at CpG sites (CT-SNPs)
• Cell Lines
  • Murine and Human Non-Hepatic Cell Lines that support Hepatitis C Virus replication
  • Scid.adh, A Thymic Cell Line That Mimics T-Cell Development In Vitro
  • Hef1/Cas-L, a Novel Signal Transduction Molecule Associated with Cell Motility, Growth, Apoptosis and Oncogenic Transformation [PDF]

Software

• ArrayExplorer^® - Image-Processing Software for cDNA Microarray Analysis

PDF files require Adobe^® Acrobat Reader to view.